Multipoint targeting of the PI3K/mTOR pathway in mesothelioma

被引：0
|
作者：
S Zhou
L Liu
H Li
G Eilers
Y Kuang
S Shi
Z Yan
X Li
J M Corson
F Meng
H Zhou
Q Sheng
J A Fletcher
W-B Ou
机构：
[1] Zhejiang Provincial Key Laboratory of Applied Enzymology,Department of Biotechnology and Biomedicine
[2] Yangtze Delta Region Institute of Tsinghua University,Department of Bioengineering
[3] College of Biology and Chemical Engineering,Department of Pathology
[4] Jiaxing University,Department of Biochemistry and Molecular Biology
[5] Brigham and Women’s Hospital and Harvard Medical School,undefined
[6] College of Life Sciences,undefined
[7] Zhejiang Sci-Tech University,undefined
来源：
British Journal of Cancer | 2014年 / 110卷
关键词：
mesothelioma; tyrosine kinases; PI3K/AKT/mTOR; PI3K/AKT/MDM2;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2479 / 2488
页数：9
相关论文
共 50 条
  • [31] Targeting the PI3K/Akt/mTOR Pathway in Malignancy: Rationale and Clinical Outlook
    Daniel C. Cho
    BioDrugs, 2014, 28 : 373 - 381
  • [32] Targeting the PI3K/AKT/mTOR pathway in cutaneous squamous cell carcinoma
    Perry, Jay Ryan
    Thind, Amarinder Singh
    Minaei, Elahe
    Ryan, Emily
    Genenger, Benjamin
    Iyer, Gopal
    Martin, Carolan
    Ashford, Bruce
    Ranson, Andmarie
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2021, 17 : 43 - 43
  • [33] Targeting the PI3K/Akt/mTOR Pathway in Malignancy: Rationale and Clinical Outlook
    Cho, Daniel C.
    BIODRUGS, 2014, 28 (04) : 373 - 381
  • [34] Overview of the PI3K/Akt/mTOR pathway
    Dennis, P. A.
    ANNALS OF ONCOLOGY, 2008, 19 : 21 - 21
  • [35] Strategies for co-targeting the PI3K/AKT/mTOR pathway in NSCLC
    Heavey, Susan
    O'Byrne, Kenneth J.
    Gately, Kathy
    CANCER TREATMENT REVIEWS, 2014, 40 (03) : 445 - 456
  • [36] mTOR/PI3k/Akt SIGNALING PATHWAY IN TUMOR ANGIOGENESIS AND THERAPEUTIC TARGETING
    Mabeta, Peace
    Davis, Paul F.
    Pepper, Michael S.
    ANTICANCER RESEARCH, 2014, 34 (10) : 6042 - 6042
  • [37] Targeting the PI3K pathway in cancer
    Workman, P.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S80 - S80
  • [38] The PI3K/mTOR Pathway in Gallbladder Carcinoma
    Primiani, A.
    Shahid, M.
    Yilmaz, O.
    Ferrone, C. R.
    Borger, D. R.
    Iafrate, A. J.
    Zhu, A. X.
    Deshpande, V.
    MODERN PATHOLOGY, 2013, 26 : 173A - 173A
  • [39] The PI3K/AKT/mTOR interactive pathway
    Ersahin, Tulin
    Tuncbag, Nurcan
    Cetin-Atalay, Rengul
    MOLECULAR BIOSYSTEMS, 2015, 11 (07) : 1946 - 1954
  • [40] Targeting the PI3K pathway in cancer
    Mills, GB
    BREAST CANCER RESEARCH AND TREATMENT, 2004, 88 : S4 - S4
12345